Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about AZN

Recent news which mentions AZN

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
AstraZeneca-Merck's Prostate Cancer Drug Under FDA Priority Review For Expanded Use
Tickers AZN AZNCF MRK
Tags Benzinga Health Care AZNCF
From Benzinga
Why Gilead Sciences Stock Was a 5% Winner Today
Tickers AZN GILD
Tags AZN Market News GILD
From Motley Fool
Benzinga Before The Bell: YouTube Plans Streaming Marketplace, Drug Pricing Bill Passes Congress, Bitcoin Could Surge To All-Time High Soon And Other Top Financial Stories Monday, August 15
Tickers AAPL AGS AMZN APO
Tags LI SASDY AAPL
From Benzinga
Landmark Drug Pricing Reform Bill Passes Congress House
Tickers AZN BNTX GSK JNJ
Tags LLY Health Care PFE
From Benzinga
AstraZeneca-Daiichi's Flagship Breast Cancer Drug Improves Survival In Late-Stage Study
Tickers AZN AZNCF DSKYF DSNKY
Tags DSKYF AZNCF Health Care
From Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
Tickers ACER APTX AZN GH
Tags Biotech Catalysts / EOD Summary General ACER
From Benzinga
Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
Tickers AZN AZNCF DSKYF DSNKY
Tags Large Cap DSNKY General
From Benzinga
This Analyst Says Zentalis' Increased Focus On WEE1 Program Is 'Prudent', Slashes Price Target By 37%
Tickers AZN ZNTL
Tags Briefs Small Cap ZNTL
From Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Tickers ARCT AXSM AYTU AZN
Tags MRSN CRMD Contracts
From Benzinga
AstraZeneca's Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients
Tickers AZN AZNCF DSKYF DSNKY
Tags Market News AZN Biotech
From Benzinga
Recap of Monday's Biotech Catalysts - End Of the Day Summary
Tickers AZN CINC ENDP HCM
Tags HCM Market News TCON
From Benzinga
AstraZeneca (AZN) Announces Approval of ENHERTU (HER2-low Metastatic Breast Cancer) in the United States
Tickers AZN
Tags News AZN Analyst Rating
From Best Stocks
Lyme Disease And Climate Change Reinvigorates Valneva's Vaccine Efforts After COVID Shot Disappointment
Tickers AZN MRNA PFE VALN
Tags Briefs Small Cap Market News
From Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
Tickers AZN EVO KTTA MRK
Tags Market News NVS PFE
From Benzinga
AstraZeneca's Tagrisso Doublet Therapy Shows 49% Response Rate In Lung Cancer Setting
Tickers AZN AZNCF HCM
Tags Benzinga AZNCF Health Care
From Benzinga
3 Unstoppable Stocks That Don't Care About the Bear Market
Tickers ABBV AZN BMY
Tags Recent Press Releases BMY ABBV
From Motley Fool
Pharmaceutical CEOs use earnings calls to criticize drug-pricing proposal
Tickers ABBV AZN BMY JNJ
Tags PFE LLY MRK
From MarketWatch
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Tickers ARQT ATXS AZN MRK
Tags Benzinga ARQT Biotech Catalysts / EOD Summary
From Benzinga
Pieris Stops Work On Cancer Med, Tested In Combo With Eli Lilly Drugs
Tickers AZN AZNCF LLY PIRS
Tags PIRS Biotech AZN
From Benzinga
AstraZeneca and Merck Receives European Commission Approval For Expanded Use In Breast Cancer Therapy
Tickers AZN MRK
Tags Health Care EC Approval Benzinga
From Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
Tickers ABUS ACAD ADAP AGIO
Tags VRTX AMGN Small Cap
From Benzinga
Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus
Tickers AZN EBS JNJ
Tags Movers Market News Small Cap
From Benzinga
Avalo Therapeutics, Apollo Therapeutics Ink Pact For Anti-IL-18 Antibody
Tickers AVTX AZN
Tags AZN Biotech General
From Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
Tickers ALXO ARQT AZN BEAM
Tags Trading Ideas News Large Cap
From Benzinga
AstraZeneca Cuts Innate-Partnered Phase 3 Trial In Head & Neck Cancer
Tickers AZN AZNCF IPHA
Tags Movers Market News Briefs
From Benzinga
Do These 3 New Moneymakers for AstraZeneca Make It a Buy?
Tickers AMGN AZN
Tags AMGN Recent Press Releases AZN
From Motley Fool
3 Stocks We Think Could Beat the Market in the Second Half of 2022
Tickers ABBV AZN JNJ
Tags JNJ Recent Press Releases ABBV
From Motley Fool
AstraZeneca Drops Moderna-Partnered, Phase 2 Heart Disease Drug Candidate
Tickers AZN AZNCF MRNA
Tags News General MRNA
From Benzinga
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
Tickers ABBV ADMP ARQT AZN
Tags Benzinga ABBV FDA
From Benzinga
Recap: AstraZeneca Q2 Earnings
Tickers AZN
Tags Benzinga BZI/Recaps AZN
From Benzinga
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.